We are live on ! Find out more
EXEL icon

Exelixis

346 hedge funds and large institutions have $5.08B invested in Exelixis in 2019 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 136 increasing their positions, 110 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more call options, than puts

Call options by funds: $86.7M | Put options by funds: $57.5M

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

24% more repeat investments, than reductions

Existing positions increased: 136 | Existing positions reduced: 110

0.98% less ownership

Funds ownership: 79.72%78.74% (-0.98%)

8% less funds holding

Funds holding: 377346 (-31)

11% less capital invested

Capital invested by funds: $5.69B → $5.08B (-$616M)

36% less first-time investments, than exits

New positions opened: 42 | Existing positions closed: 66

Holders
346
Holders Change
-31
Holders Change %
-8.22%
% of All Funds
7.52%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
42
Increased
136
Reduced
110
Closed
66
Calls
$86.7M
Puts
$57.5M
Net Calls
+$29.2M
Net Calls Change
-$48.9M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$656M -$4.02M -191,763 -0.6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$593M +$784K +37,388 +0.1%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$351M -$88.1M -4,203,601 -20%
MG
4
Meditor Group
Bermuda
$321M -$1.96M -93,422 -0.6%
AQR Capital Management
5
AQR Capital Management
Connecticut
$293M -$45.3M -2,159,602 -14%
Renaissance Technologies
6
Renaissance Technologies
New York
$288M +$81.5M +3,889,200 +41%
State Street
7
State Street
Massachusetts
$217M +$4.68M +223,461 +2%
JP Morgan Chase
8
JP Morgan Chase
New York
$171M -$41.7M -1,988,496 -20%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$131M +$22M +1,051,976 +21%
First Trust Advisors
10
First Trust Advisors
Illinois
$125M +$9.08M +433,202 +8%
Goldman Sachs
11
Goldman Sachs
New York
$106M -$36.1M -1,724,399 -26%
O
12
OrbiMed
New York
$83.6M +$23.3M +1,111,000 +40%
BG
13
Bellevue Group
Switzerland
$82.9M +$78.3M +3,738,300 +2,661%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$80.8M +$1.51M +71,830 +2%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$71.3M +$3.81M +181,560 +6%
Fiera Capital (Canada)
16
Fiera Capital (Canada)
Quebec, Canada
$65.4M +$12.7M +606,116 +25%
FCM
17
Frontier Capital Management
Massachusetts
$64.9M +$4.55M +217,026 +8%
FCM
18
Farallon Capital Management
California
$64.1M
Norges Bank
19
Norges Bank
Norway
$61.7M +$1.26M +60,271 +2%
PAMU
20
Pictet Asset Management (UK)
United Kingdom
$57.7M +$3.66M +174,415 +7%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$55.2M +$8.7M +415,263 +19%
Northern Trust
22
Northern Trust
Illinois
$51.9M +$609K +29,045 +1%
N
23
Nuveen
North Carolina
$47.3M +$46.4M +2,213,810 New
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$44M +$1.56M +74,554 +4%
Prudential Financial
25
Prudential Financial
New Jersey
$36.5M +$17.8M +847,708 +98%

EXEL Hedge Fund Activity: Q2 2019 in Review

346 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q2 2019, worth a combined $5.08B — down 11% from $5.69B a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of EXEL and 42 opened new positions — a net loss of 24 holders — while 110 trimmed existing stakes and 136 added.

The largest buyer was Renaissance Technologies, adding an estimated $81.5M. The largest seller was Fidelity Investments, cutting an estimated $88.1M.

  • 346 institutional investors held Exelixis (EXEL) as of Q2 2019, down from 377 in Q1 2019.
  • Funds reported $5.08B of Exelixis stock for Q2 2019, down 11% quarter-over-quarter.
  • 42 funds opened new Exelixis positions in Q2 2019 and 66 closed out, a net change of -24 holders.
  • The largest Exelixis buyer in Q2 2019 was Renaissance Technologies, an estimated $81.5M added.
  • The largest Exelixis seller in Q2 2019 was Fidelity Investments, an estimated $88.1M sold.

Based on aggregated 13F filings for Q2 2019.